Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells.

Miles SL, Fischer AP, Joshi SJ, Niles RM.

BMC Cancer. 2015 Nov 7;15:867. doi: 10.1186/s12885-015-1878-5.

2.

Identification of the PS1 Thr147Ile Variant in a Family with Very Early Onset Dementia and Expressive Aphasia.

Denvir J, Neitch S, Fan J, Niles RM, Boskovic G, Schreurs BG, Primerano DA, Alkon DL.

J Alzheimers Dis. 2015;46(2):483-90. doi: 10.3233/JAD-150051.

3.

Molecular and physiological actions of quercetin: need for clinical trials to assess its benefits in human disease.

Miles SL, McFarland M, Niles RM.

Nutr Rev. 2014 Nov;72(11):720-34. doi: 10.1111/nure.12152. Epub 2014 Oct 16. Review.

PMID:
25323953
4.

Draft Genome Sequences of Two Alginate-Overproducing Variants of Pseudomonas aeruginosa, PAO1-VE2 and PAO1-VE13.

Yin Y, Withers TR, Niles RM, Johnson SL, Yu HD.

Genome Announc. 2013 Dec 12;1(6). pii: e01031-13. doi: 10.1128/genomeA.01031-13.

5.

A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes.

Miles SL, Niles RM, Pittock S, Vile R, Davies J, Winters JL, Abu-Yaghi NE, Grothey A, Siddiqui M, Kaur J, Hartmann L, Kalli KR, Pease L, Kravitz D, Markovic S, Pulido JS.

Retina. 2012 Oct;32(9):1959-66.

PMID:
22791177
6.

Silencing and re-expression of retinoic acid receptor beta2 in human melanoma.

Fan J, Eastham L, Varney ME, Hall A, Adkins NL, Chetel L, Sollars VE, Georgel P, Niles RM.

Pigment Cell Melanoma Res. 2010 Jun;23(3):419-29. doi: 10.1111/j.1755-148X.2010.00702.x. Epub 2010 Mar 29. Erratum in: Pigment Cell Melanoma Res. 2010 Oct;23(5):722. Chetel, Lora [added].

PMID:
20374520
7.

Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.

Mills CN, Joshi SS, Niles RM.

Mol Cancer. 2009 Nov 17;8:104. doi: 10.1186/1476-4598-8-104.

8.

Expression and function of CD9 in melanoma cells.

Fan J, Zhu GZ, Niles RM.

Mol Carcinog. 2010 Jan;49(1):85-93. doi: 10.1002/mc.20580.

9.
10.

Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition.

Huang Y, Minigh J, Miles S, Niles RM.

J Mol Signal. 2008 Feb 12;3:3. doi: 10.1186/1750-2187-3-3.

11.

PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells.

Eastham LL, Mills CN, Niles RM.

Pharm Res. 2008 Jun;25(6):1327-33. doi: 10.1007/s11095-007-9524-9.

PMID:
18172578
12.
13.

Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth.

Niles RM, Cook CP, Meadows GG, Fu YM, McLaughlin JL, Rankin GO.

J Nutr. 2006 Oct;136(10):2542-6.

14.

Thimerosal induces apoptosis in a neuroblastoma model via the cJun N-terminal kinase pathway.

Herdman ML, Marcelo A, Huang Y, Niles RM, Dhar S, Kiningham KK.

Toxicol Sci. 2006 Jul;92(1):246-53. Epub 2006 Apr 19.

15.

Signaling pathways in retinoid chemoprevention and treatment of cancer.

Niles RM.

Mutat Res. 2004 Nov 2;555(1-2):81-96. Review.

PMID:
15476854
16.
17.

Resveratrol is a potent inducer of apoptosis in human melanoma cells.

Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, Meadows GG.

Cancer Lett. 2003 Feb 20;190(2):157-63.

PMID:
12565170
18.
19.
20.

Regulation of retinoic acid receptor alpha by protein kinase C in B16 mouse melanoma cells.

Boskovic G, Desai D, Niles RM.

J Biol Chem. 2002 Jul 19;277(29):26113-9. Epub 2002 May 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk